Apyx Medical (APYX) Receivables - Net (2010 - 2026)

Apyx Medical (APYX) has 17 years of Receivables - Net data on file, last reported at $12.8 million in Q1 2026.

• For the quarter ending Q1 2026, Receivables - Net rose 9.53% year-over-year to $12.8 million; the trailing twelve-month figure through Mar 2026 stood at $12.8 million (up 9.53% YoY), and the FY2025 full-year result was $16.8 million, up 8.37% from the prior year.
• Receivables - Net for Q1 2026 stood at $12.8 million, down from $16.8 million in the prior quarter.
• Across five years, Receivables - Net topped out at $16.8 million in Q4 2025 and bottomed at $9.1 million in Q3 2022.
• The 5-year median for Receivables - Net is $12.5 million (2024), against an average of $12.4 million.
• Peak annual rise in Receivables - Net reached 60.91% in 2022, while the deepest fall reached 20.53% in 2022.
• A 5-year view of Receivables - Net shows it stood at $10.6 million in 2022, then jumped by 32.27% to $14.0 million in 2023, then increased by 10.39% to $15.5 million in 2024, then grew by 8.37% to $16.8 million in 2025, then dropped by 23.97% to $12.8 million in 2026.
• The last three Receivables - Net figures came in at $12.8 million (Q1 2026), $16.8 million (Q4 2025), and $13.0 million (Q3 2025), per Business Quant data.

Peer Comparison